Cell therapies are already here, with treatments now available for some cancers and rare diseases. But bringing such living medicines to more patients presents both scientific and financial challenges ...
CHICAGO--(BUSINESS WIRE)--Syntax Bio, a preclinical-stage biotechnology company, has launched with backing from Astellas Venture Management LLC and Illumina Ventures. Other investors include DCVCBio, ...
Veteran marketing leader to drive global growth and brand presence of Syntax as a trusted technology solutions and services partner for mission-critical business applications and cloud transformations ...
This week’s episode features Michelle Smith, Vice President of the Global Mining Practice at Syntax, in discussion with host ...
As Oracle plots out its continued cloud expansion, it's expecting to grow the business by attracting both new customers and customers already using Oracle software. It'll be getting some help with its ...
NEW YORK--(BUSINESS WIRE)--Syntax Advisors LLC, an ETF sponsor and investment advisor (NYSE Arca: SSPY, SMDY, SSLY, SYUS, SHUS), announced today the appointment of Carly Arison to serve as President ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results